Accenture said it was combining several of its services into one business unit, part of a change of a broader effort tied to the time of growing artificial intelligence adoption, effective Sept. 1.
Accenture (ACN) stock fell in premarket trading Friday as the professional services firm's fiscal third-quarter bookings fell short of analysts' estimates.
ACN is set to report third-quarter fiscal 2025 results, with growth across all segments and a 5.1% y/y EPS increase.
Beyond analysts' top -and-bottom-line estimates for Accenture (ACN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended May 2025.
I maintain my Hold rating on Accenture plc, as growth remains modest, and the stock appears overvalued despite recent share price declines. Q3 expectations are for slight beats on revenue and EPS, but I don't expect these to drive meaningful upside in the share price. I'm watching for sustained momentum in new bookings, especially in GenAI, and want to see more aggressive top-line growth and operational improvements.
Accenture's Julie Sweet discusses the growth of AI, macro uncertainty, the UK market and DEI policy
In the most recent trading session, Accenture (ACN) closed at $320.92, indicating a +1.36% shift from the previous trading day.
Given the decline in ACN's share price, we evaluate its current position to find out whether it offers a good investment opportunity now.
Accenture (ACN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In the closing of the recent trading day, Accenture (ACN) stood at $314.47, denoting a -0.74% change from the preceding trading day.
David Droga's sale of his namesake agency to Accenture in 2019 gave momentum to consultancies' move into marketing services.
The latest trading day saw Accenture (ACN) settling at $315.43, representing a +1.89% change from its previous close.